Cargando…
IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling
Diabetic retinopathy (DR), one of the most serious complications of diabetes, has been associated with inflammatory processes. We have recently reported that interleukin (IL)-17A, a proinflammatory cytokine, is increased in the plasma of diabetic patients. Further investigation is required to clarif...
Autores principales: | Qiu, Ao-Wang, Bian, Zheng, Mao, Ping-An, Liu, Qing-Huai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192073/ https://www.ncbi.nlm.nih.gov/pubmed/27980343 http://dx.doi.org/10.1038/emm.2016.117 |
Ejemplares similares
-
IL-17A injury to retinal ganglion cells is mediated by retinal Müller cells in diabetic retinopathy
por: Qiu, Ao-Wang, et al.
Publicado: (2021) -
IL-33 regulates Müller cell-mediated retinal inflammation and neurodegeneration in diabetic retinopathy
por: Augustine, Josy, et al.
Publicado: (2023) -
IL-17 signaling and A20: A balancing act
por: Garg, Abhishek V, et al.
Publicado: (2013) -
Müller Cell–Microglia Cross Talk Drives Neuroinflammation in Diabetic Retinopathy
por: Abcouwer, Steven F.
Publicado: (2017) -
The role of retinal Müller cells in diabetic retinopathy and related therapeutic advances
por: Yang, Shuo, et al.
Publicado: (2022)